Amrinone (Standard)
Amrinone (Standard) is the analytical standard of Amrinone. This product is intended for research and analytical applications. Amrinone (Inamrinone) is a positive inotropic-vasodilator agent. Amrinone is a selective phosphodiesterase III inhibitor that increases cyclic adenosine monophosphate by preventing its breakdown. Amrinone is also an orally active, non-glycosidic and non-catecholamine cardiotonic agent.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 60719-84-8
- Formule: C10H9N3O
- Masse moléculaire:187.20
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-B1294
AmrinonePhosphodiesterase III Inhibitor -
HY-14252
Milrinone -
HY-12085
ApremilastPDE-4 Inhibitor -
HY-117383
NGI-1Virus Protease Inhibitor -
HY-12085R
Apremilast (Standard)PDE-4 Inhibitor -
HY-N0076
BilobalideNeuroprotective Sesquiterpene -
HY-N0076R
Bilobalide (Standard)Neuroprotective Sesquiterpene -
HY-112831
OsoresnontrinePDE9A Inhibitor -
HY-102027
FX1BCL6 Inhibitor -
HY-17361
EtofenamateCOX Inhibitor -
HY-14252R
Milrinone (Standard) -
HY-17361R
Etofenamate (Standard)COX Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 60719-84-8
-
Masse moléculaire 187.20
-
Formule C10H9N3O
-
SMILES
O=C1C(N)=CC(C2=CC=NC=C2)=CN1
-
Synonyms
Inamrinone (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. A A Alousi, et al. The Beneficial Effect of Amrinone on Acute Drug-Induced Heart Failure in the Anaesthetised Dog. Cardiovasc Res. 1985 Aug;19(8):483-94. [Content Brief]
[2]. S Ichioka, et al. Clinical Use of Amrinone (A Selective Phosphodiesterase III Inhibitor) in Reconstructive Surgery. Plast Reconstr Surg. 2001 Dec;108(7):1931-7. [Content Brief]
[3]. T H LeJemtel, et al. Amrinone: A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man. Circulation. 1979 Jun;59(6):1098-104. [Content Brief]
[4]. M Hachisu, et al. [Effects of Amrinone, an Inhibitor of c-AMP-specific Phosphodiesterases, on Neointimal Hyperplasia After Balloon Injury in Rats]. Nihon Yakurigaku Zasshi. 1998 Oct;112(4):267-74. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Amrinone (Standard) Related Classifications
HY-B1294R Related Classifications
Powered by Bioz